Relmada Therapeutics, Inc.

NASDAQ:RLMD

Biotechnology

Healthcare
$3.11 -0.97%

-$0.06 today

Market cap
$331.82M
Beta
0.39
P/E (TTM)
-9.6
EPS (TTM)
-$0.68
52W Low $0.52High $8.00

Volume 1.71M

Average 1.24M

Balance Sheet

Inspect the capital base behind the business.

Assets

$94.00M

FY 2025 · Annual

+105.2% YoY

Liabilities

$7.49M

FY 2025 · Annual

-27.2% YoY

Equity

$86.51M

FY 2025 · Annual

+143.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents44.44M5.4M4.09M3.86M3.5M
Short-term Investments167.47M142.93M92.23M41.05M89.51M
Net Receivables86.38K512.43K000
Inventory00000
Other Current Assets350000
Total Current Assets223.3M152.87M97.51M45.8M93.98M
Property, Plant & Equipment (Net)00000
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets28.29K34.88K43.13K21.98K19.5K
Total Non-current Assets28.29K34.88K43.13K21.98K19.5K
Total Assets223.33M152.91M97.55M45.82M94M
Account Payables11.19M5.26M3.51M4.13M1.57M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.64M1.02M5.68M1.15M535.48K
Total Current Liabilities15.06M12.47M12.19M10.29M6.43M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0004.47K1.06M
Total Non-current Liabilities0004.47K1.06M
Total Liabilities15.06M12.47M12.19M10.3M7.49M
Common Stock27.74K30.1K30.1K30.17K73.33K
Retained Earnings(305.07M)(462.11M)(560.9M)(640.88M)(698.27M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity208.26M140.44M85.36M35.52M86.51M
Total Debt00000
Net Debt(44.44M)(5.4M)(4.09M)(3.86M)(3.5M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$9.8M
Short-term Investments$224.2M
Other Current$1.4M
Total Current Assets$235.3M
Other Non-current$19.5K
Total Non-current Assets$19.5K
Total Assets$235.4M

Analysis

Selected assets total $235.4M for Latest. The largest visible component is Short-term Investments at $224.2M, about 95.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
4Statement of changes in beneficial ownershipSep 11, 2026
4Statement of changes in beneficial ownershipSep 11, 2026
8-KCurrent reportSep 8, 2026

How much cash does RLMD have?

Relmada Therapeutics, Inc. (RLMD) reported $3.50M in cash and equivalents in fiscal 2025.

How much debt does RLMD carry?

Relmada Therapeutics, Inc. (RLMD) reported $0.00 of total debt, with net debt of -$3.50M.